Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.100 Biomarker phenotype BEFREE These results indicate that EGF and TGF-alpha successively evoke cascade phenomena which favor tumor progression, invasion and extracellular matrix formation, acting as autocrine growth regulators for gastric carcinomas. 2168868 1990
Entrez Id: 4613
Gene Symbol: MYCN
MYCN
0.100 AlteredExpression phenotype BEFREE No correlation was found between MDR1 or N-myc genes expression and tumor progression. 1974410 1990
Entrez Id: 1950
Gene Symbol: EGF
EGF
0.100 Biomarker phenotype BEFREE The understanding of the significance of EGF-related growth factors in tumor progression provides a framework for a biological approach to the therapy of human gastrointestinal carcinomas. 2157713 1990
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.100 Biomarker phenotype BEFREE Moreover, they stimulate the expression of metalloproteinase genes suggesting that EGF and TGF-alpha successively evoke cascade phenomena which are most convenient for tumor progression, invasion and metastasis. 2098274 1990
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 GeneticVariation phenotype BEFREE Amplification and/or overexpression of the c-myc gene were frequently observed in advanced-stage cervical cancers and were shown to be associated with tumor progression. 2173473 1990
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 Biomarker phenotype BEFREE The production of TNF by human ovarian cancer cells may influence the biology of the tumour, contribute to neoplastic progression and alter the response to therapy. 2148874 1990
Entrez Id: 1950
Gene Symbol: EGF
EGF
0.100 Biomarker phenotype BEFREE Moreover, they stimulate the expression of metalloproteinase genes suggesting that EGF and TGF-alpha successively evoke cascade phenomena which are most convenient for tumor progression, invasion and metastasis. 2098274 1990
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 AlteredExpression phenotype BEFREE In order to examine the role of the erbB-2 oncogene in human breast cancer, gene amplification and expression were examined in multiple stages of tumor progression. 2208136 1990
Entrez Id: 4602
Gene Symbol: MYB
MYB
0.040 Biomarker phenotype BEFREE In the present study we have analysed in breast cancer the c-myb gene with the aim to determine its involvement in tumour progression. 2181374 1990
Entrez Id: 4763
Gene Symbol: NF1
NF1
0.040 Biomarker phenotype BEFREE The NF1 gene has been mapped to a small region of chromosome 17q, but neither the nature of the primary defect nor the mechanisms involved in tumor progression are understood. 2142531 1990
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 Biomarker phenotype BEFREE Amplification of the myc gene proved to occur during a late stage of tumor progression and is not an early initiating event resulting from the direct action of radiation on target cells. 1773800 1991
Entrez Id: 4830
Gene Symbol: NME1
NME1
0.100 AlteredExpression phenotype BEFREE Tumor progression to the metastatic phenotype is accompanied in certain cell types by reduced expression of the nm23 gene. 2015608 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 Biomarker phenotype BEFREE These results suggest that (i) significant differences in the frequency of p53 mutations are present among subtypes of neoplasms derived from the same tissue; (ii) p53 may play a role in tumor progression in B-cell chronic lymphocytic leukemia; (iii) the presence of both p53 loss/inactivation and c-myc oncogene activation may be important in the pathogenesis of Burkitt lymphoma and its leukemic form L3-type B-cell acute lymphoblastic leukemia. 2052620 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression phenotype BEFREE Marked expression of p53 appears to relate to tumour progression. 1684809 1991
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100 AlteredExpression phenotype BEFREE These data indicate that HPV genomes are preferentially integrated near myc genes in invasive genital cancers and support the hypothesis that integration plays a part in tumor progression via an activation of cellular oncogenes. 1649348 1991
Entrez Id: 57508
Gene Symbol: INTS2
INTS2
0.040 Biomarker phenotype BEFREE Our data suggest relationships between tumor progression and both incidence and size of Myc, Neu, and Int-2 gene amplification. 1849359 1991
Entrez Id: 2248
Gene Symbol: FGF3
FGF3
0.040 Biomarker phenotype BEFREE Our data suggest relationships between tumor progression and both incidence and size of Myc, Neu, and Int-2 gene amplification. 1849359 1991
Entrez Id: 5915
Gene Symbol: RARB
RARB
0.030 AlteredExpression phenotype BEFREE Abnormally low expression of the RAR beta receptor may contribute to neoplastic progression in stratified squamous epithelia. 1713123 1991
Entrez Id: 5741
Gene Symbol: PTH
PTH
0.010 AlteredExpression phenotype BEFREE Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. 1742725 1991
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 GeneticVariation phenotype BEFREE The higher frequency of mutations in cell lines (70%) suggests that mutation of p53 may be associated with tumor progression. 1638540 1992
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.100 AlteredExpression phenotype BEFREE It has been believed to play a role in tumor initiation by inducing the reversible transformed phenotype; overexpression of TGF-alpha may be important for tumor progression via autocrine stimulation and oncogene overexpression. 1468772 1992
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
0.100 AlteredExpression phenotype BEFREE The direct relation of p53 protein alterations with c-erbB-2 overexpression may be interpreted in light of the multistep model of tumor progression. 1357956 1992
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression phenotype BEFREE Low-grade lymphoma of small lymphocytic type disclosed p53+ large cells (paraimmunoblasts) that may play a role in tumor progression in this lymphoma subtype. p53 was also strongly expressed in the nuclei of Reed Sternberg cells from 19 of 37 cases of Hodgkin's disease, including six cases of mixed cellularity, and 13 cases of nodular sclerosing type. 1466398 1992
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100 AlteredExpression phenotype BEFREE In contrast to the findings at the DNA level the EGFR expression, analysed by immunohistochemical techniques, showed a more heterogeneous pattern after tumour progression. 1447576 1992
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100 AlteredExpression phenotype BEFREE Immunohistochemical staining of a large series of human cutaneous melanocytic lesions using the method selected showed differential EGFR expression in various stages of melanocytic tumor progression: 19% of common nevocellular nevi; 61% of dysplastic nevi, 89% of primary cutaneous melanomas, and 91% of melanoma metastases showed staining of the melanocytic cells. 1629628 1992